Ads
related to: clinical trials phases
Search results
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 3 days agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
FDA grants RMAT status for BlueRock’s Parkinson’s therapy
Pharmaceutical Technology via Yahoo Finance· 8 hours agoBlueRock Therapeutics president and CEO Seth Ettenberg stated: “We are excited about the positive...
Groundbreaking human trial for tooth regeneration drug set to begin
The Washington Times· 1 day agoThe world’s first clinical trial of a drug designed to regenerate human teeth is slated to start in...
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial
MedPage Today· 13 hours agoFive-year results from a phase III trial had experts gushing over lorlatinib's (Lorbrena)...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 2 days agoThe product’s formulation includes low doses of Tetrahydrocannabinol (THC), the main psychoactive...
TONI SAYS: Does Medicare Part D cover prescriptions for clinical trials?
Odessa American· 2 days agoAre clinical trial prescriptions covered under Medicare’s drug plans? What a smart decision you made to stay on Sarah’s employer benefits, because you both ...
Does Medicare Part D cover prescriptions for clinical trials? | Chattanooga Times Free Press
Chattanooga Times Free Press· 6 days agoAre clinical trial prescriptions covered under Medicare's drug plans? What a smart decision you made...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morning Times· 4 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase 3 ...
Immunocore gains as Mizuho maintains 'buy' rating By Investing.com
Investing.com· 2 days agoOn Wednesday, Immunocore Holdings (NASDAQ:IMCR), a biotechnology company, announced a significant...